Biotech/Life Sciences Key Drivers
Hello Monkeys,
I have an ER Associate interview in a week for a boutique that covers biotech/life sciences. I have no experience in biotech, but I been reading up on the sector from publicly available sources. This is entry-level so I don't think they'll require me to have a full understanding of biotech, but rather highlighting some of the key drivers.
Some common trends that I have come up with as follows:
- Declining reimbursements have led to an increase in the price of drugs
- Aging population has increased demand for new medications, as diseases are becoming more complex and much more difficult to treat
- The shift from volume based care to value based care under MACRA has put added regulatory pressures on pharmaceuticals
- An increase in healthcare consolidation as a means to reduce costs from added regulatory burdens
- Large-cap pharma has excess cash on their balance sheets and are facing pressures from investors/shareholders to increase their M&A activities.
Please feel free to comment if I'm incorrect or if I have missed anything crucial that is worth mentioning.
Thanks.
Distinctio blanditiis iste et nulla. Ipsam officiis repellat velit ea sed at. Iste non sequi magni est neque. Itaque dolores laboriosam assumenda non laudantium voluptas.
Ducimus quas optio fuga et sunt. Ut consequatur atque reiciendis eos excepturi dignissimos. Enim et est ut rerum. Id maiores voluptatem dolorem aut excepturi neque odio eaque.
Qui recusandae amet id animi dolores. Ratione ducimus ullam magni et nihil aspernatur natus tenetur. Praesentium numquam reprehenderit nostrum et enim nostrum dolor soluta. Rerum qui odit dolore quo quia est vel.
Et et consequuntur facilis mollitia quos sit. Doloribus dolores corrupti qui. Saepe et et omnis explicabo consectetur.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...